These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 22110212

  • 1. Prolonged administration of temozolomide in adult patients with anaplastic glioma.
    Freyschlag CF, Smolczyk DR, Janzen E, Schmieder K, Thomé C, Lohr F, Wenz F, Weiss C, Tuettenberg J, Seiz M.
    Anticancer Res; 2011 Nov; 31(11):3873-7. PubMed ID: 22110212
    [Abstract] [Full Text] [Related]

  • 2. [Favourable result for temozolomide in recurrent high-grade glioma].
    Taal W, van der Rijt CD, Sillevis Smitt PA, Kros JM, van Heuvel I, Enting RH, van den Bent MJ.
    Ned Tijdschr Geneeskd; 2005 Jun 18; 149(25):1393-9. PubMed ID: 15997692
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. "One week on-one week off": efficacy and side effects of dose-intensified temozolomide chemotherapy: experiences of a single center.
    Galldiks N, Berhorn T, Blau T, Dunkl V, Fink GR, Schroeter M.
    J Neurooncol; 2013 Apr 18; 112(2):209-15. PubMed ID: 23299464
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.
    Chinot OL, Honore S, Dufour H, Barrie M, Figarella-Branger D, Muracciole X, Braguer D, Martin PM, Grisoli F.
    J Clin Oncol; 2001 May 01; 19(9):2449-55. PubMed ID: 11331324
    [Abstract] [Full Text] [Related]

  • 8. Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study.
    Brandes AA, Ermani M, Basso U, Amistà P, Berti F, Scienza R, Rotilio A, Pinna G, Gardiman M, Monfardini S.
    Ann Oncol; 2001 Feb 01; 12(2):255-7. PubMed ID: 11300334
    [Abstract] [Full Text] [Related]

  • 9. A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme.
    Aoki T, Mizutani T, Ishikawa M, Sugiyama K, Hashimoto N.
    Int J Clin Oncol; 2003 Oct 01; 8(5):301-4. PubMed ID: 14586755
    [Abstract] [Full Text] [Related]

  • 10. Temozolomide in the treatment of recurrent malignant glioma in Chinese patients.
    Chan DT, Poon WS, Chan YL, Ng HK.
    Hong Kong Med J; 2005 Dec 01; 11(6):452-6. PubMed ID: 16340021
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, Motta F, Lanzafame S, Scaglione G, Longo A, Albanese V, Certo F.
    Neurosurg Focus; 2014 Dec 01; 37(6):E4. PubMed ID: 25434389
    [Abstract] [Full Text] [Related]

  • 14. Effects of palliative treatment with temozolomide in patients with high-grade gliomas.
    Ziobro M, Rolski J, Grela-Wojewoda A, Zygulska A, Niemiec M.
    Neurol Neurochir Pol; 2008 Dec 01; 42(3):210-5. PubMed ID: 18651326
    [Abstract] [Full Text] [Related]

  • 15. Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide.
    Kong DS, Kim HR, Choi YR, Seol HJ, Lee JI, Nam DH.
    J Clin Neurosci; 2015 Sep 01; 22(9):1425-9. PubMed ID: 26138051
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial.
    Chamberlain MC, Colman H, Kim BT, Raizer J.
    J Neurooncol; 2017 Feb 01; 131(3):507-516. PubMed ID: 28204914
    [Abstract] [Full Text] [Related]

  • 18. Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study.
    Kim YH, Park CK, Cho WH, Kim IA, Moon S, Choe G, Park SH, Kim IH, Kim DG, Jung HW, Lee MM, Bae SH, Cha SH, Kim CY.
    J Neurooncol; 2011 Jul 01; 103(3):503-12. PubMed ID: 20862518
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma.
    Kocher M, Kunze S, Eich HT, Semrau R, Müller RP.
    Strahlenther Onkol; 2005 Mar 01; 181(3):157-63. PubMed ID: 15756519
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.